Answers are grounded in this paper and cite their sources.
INTRODUCTION: The gold standard for diagnosing endogenous hyperinsulinemic hypoglycaemia (EHH) is the fasting test. The respective diagnostic value of insulin, C-peptide, proinsulin and beta-hydroxybutyrate levels in relation to glucose levels at the end of the fasting test remains ill-defined. We, therefore, aimed to explore the relevance of these parameters based on a literature review and individual data provided by different authors. METHODS: Extensive literature research was conducted in the databases Embase and Medline to identify case reports and original studies that report data on the fasting test e.g. fasting duration, blood glucose and insulin levels at the end of the fast, as well as C-peptide, proinsulin and beta-hydroxybutyrate levels, where available. Histology after surgery was defined as the diagnostic gold standard for patients with positive fasting tests. RESULTS: Data on fasting tests of 522 individual patients and 36 individual controls were identified. Sensitivity and specificity of the fasting test were 75.7% [95%CI 71.8-79.2] and 94.4% [95%CI 81.9-98.5], respectively, in our cohort. Whereas blood glucose, insulin and C-peptide are measured and reported in most cases, proinsulin and beta-hydroxybutyrate were reported in only 51% and 50%, respectively. In relation to blood glucose levels, C-peptide concentrations reached higher diagnostic accuracy (AUC 0.97) than insulin (AUC 0.93). Meanwhile, proinsulin and beta-hydroxybutyrate had an even higher diagnostic accuracy (both AUC = 0.99). CONCLUSIONS: In our dataset, combined glucose and C-peptide showed a strong discriminatory performance for EHH. However, proinsulin and beta-hydroxybutyrate show the highest diagnostic accuracy for diagnosing EHH yet are not measured on a regular basis.
No takes yet. Share an insight, caveat, or question.
Romberg et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: